Global (English)
▾
Global
English
✓
United States
English
Europe
English
Italiano
Latin America
Português
Español
Contact Us
Product
Publication
Knowledge
Education
Training
Video Resources
News
News & Insight
Events
About
English
English
Português
Español
Italiano
European English
United States English
Contact Us
Global (English)
▾
Global
English
✓
United States
English
Europe
English
Italiano
Latin America
Português
Español
Product
Publication
Knowledge
Education
Training
Video Resources
News
News & Insight
Events
About
English
English
Português
Español
Italiano
European English
United States English
Contact Us
Category
Wound Care
Training
,
Wound Care
•
2025-05-27
•
Nelly Wang
Treatment of Diabetic Foot Ulcers
The treatment process for diabetic foot is extremely complex and requires collaboration across multidisciplinary team members.
Read More
Training
,
Wound Care
•
2025-01-17
•
Nelly Wang
Daily Care of Diabetic Foot Ulcers
To effectively prevent the occurrence of foot ulcers, it is essential to engage in proper foot care, undergo regular examinations, and address arterial hardening.
Read More
Recent articles
ON101 Named Among the Global Top 15 in the ADA 2026 Innovation Challenge
2026-05-29
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by Health Canada.
2026-05-11
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by ThaiFDA.
2026-05-11
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by AMMPS Morocco.
2026-04-10
EU NB issued the EU market approval for Bonvadis® that grants marketing authorization across all 27 EU member states for acute and chronic wounds, and scar management.
2026-03-12
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia.
2026-02-22
The medical device registration application of Bonvadis® for all indications of wounds has been accepted by INVIMA Colombia.
2026-01-31
